Comparison of Remimazolam With Flumazenil vs. Propofol During RFCA for Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

April 25, 2023

Study Completion Date

April 25, 2023

Conditions
Recovery
Interventions
DRUG

Remimazolam Besylate

Remimazolam Besylate is used as intervention drug for general anesthesia, which followed by flumazenil administration at the end of anesthesia, to be compared to propofol total intravenous anesthesia during radiofrequency catheter ablation of atrial fibrillation.

DRUG

Flumazenil

Flumazenil is used as additional intervention drug to facilitate emergence from general anesthesia in the Remimazolam with Flumazenil group.

DRUG

Propofol

Propofol is used as active comparator drug for general anesthesia until the end of anesthesia, to be compared to remimazolam besylate during radiofrequency catheter ablation of atrial fibrillation.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER